Total Payments
$70,386
2024 Payments
$125.63
Companies
20
Transactions
89
Medicare Patients
2,183
Medicare Billing
$202,060
Payment Breakdown by Category
Consulting$39,532 (56.2%)
Other$24,210 (34.4%)
Travel$3,334 (4.7%)
Food & Beverage$3,211 (4.6%)
Education$97.50 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $39,532 | 19 | 56.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,861 | 6 | 25.4% |
| Honoraria | $6,350 | 3 | 9.0% |
| Travel and Lodging | $3,334 | 11 | 4.7% |
| Food and Beverage | $3,211 | 48 | 4.6% |
| Education | $97.50 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ferring Pharmaceuticals Inc. | $16,969 | 17 | $0 (2020) |
| Myovant Sciences Inc. | $11,671 | 6 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $8,686 | 14 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $8,520 | 7 | $0 (2020) |
| TOLMAR Pharmaceuticals, Inc. | $5,531 | 3 | $0 (2019) |
| Ferring International Center SA | $4,975 | 2 | $0 (2020) |
| Clovis Oncology, Inc. | $3,281 | 8 | $0 (2019) |
| Ferring Sendirian Berhad | $2,785 | 1 | $0 (2020) |
| Astellas Pharma US Inc | $2,259 | 1 | $0 (2021) |
| HILL-ROM SERVICES, INC | $1,500 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.63 | 1 | PFIZER INC. ($125.63) |
| 2023 | $951.89 | 4 | PFIZER INC. ($932.91) |
| 2022 | $1,260 | 3 | Janssen Scientific Affairs, LLC ($1,100) |
| 2021 | $14,992 | 8 | Myovant Sciences Inc. ($11,671) |
| 2020 | $11,600 | 12 | Ferring International Center SA ($4,975) |
| 2019 | $23,283 | 29 | Ferring Pharmaceuticals Inc. ($12,201) |
| 2018 | $10,678 | 19 | Bayer HealthCare Pharmaceuticals Inc. ($6,224) |
| 2017 | $7,496 | 13 | Ferring Pharmaceuticals Inc. ($3,380) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/03/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $125.63 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2023 | PFIZER INC. | ORGOVYX (Drug) | Consulting Fee | Cash or cash equivalent | $740.00 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $63.03 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Interventional Urology | ||||||
| 01/21/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $129.88 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2022 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Diagnostic Imaging | ||||||
| 01/12/2022 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 01/11/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $141.22 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/20/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,580.00 | General |
| Category: HORMONE THERAPY | ||||||
| 12/17/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Travel and Lodging | Cash or cash equivalent | $134.40 | General |
| Category: HORMONE THERAPY | ||||||
| 12/16/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,580.00 | General |
| Category: HORMONE THERAPY | ||||||
| 12/10/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $81.22 | General |
| Category: HORMONE THERAPY | ||||||
| 12/08/2021 | Blue Earth Diagnostics Limited | Axumin (Drug) | Consulting Fee | Cash or cash equivalent | $1,062.50 | General |
| Category: Diagnostic Imaging | ||||||
| 11/30/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,715.00 | General |
| Category: HORMONE THERAPY | ||||||
| 11/30/2021 | Astellas Pharma US Inc | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $2,258.75 | General |
| Category: Oncology | ||||||
| 03/10/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,580.00 | General |
| Category: HORMONE THERAPY | ||||||
| 12/16/2020 | Ferring Sendirian Berhad | FIRMAGON (Drug) | Consulting Fee | Cash or cash equivalent | $2,785.00 | General |
| Category: UROLOGY | ||||||
| 11/12/2020 | Ferring International Center SA | FIRMAGON (Drug) | Consulting Fee | Cash or cash equivalent | $2,775.00 | General |
| Category: UROLOGY | ||||||
| 07/10/2020 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $2,296.00 | General |
| Category: Oncology | ||||||
| 06/24/2020 | Ferring International Center SA | FIRMAGON (Drug) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: UROLOGY | ||||||
| 04/06/2020 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,114.00 | General |
| Category: UROLOGY | ||||||
| 02/13/2020 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $82.89 | General |
| Category: UROLOGY | ||||||
| 01/25/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $101.18 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $114.33 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2020 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 364 | 393 | $180,698 | $24,957 |
| 2022 | 11 | 599 | 696 | $331,531 | $48,340 |
| 2021 | 13 | 618 | 713 | $742,553 | $76,571 |
| 2020 | 10 | 602 | 697 | $385,776 | $52,191 |
Total Patients
2,183
Total Services
2,499
Medicare Billing
$202,060
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 86 | 86 | $31,132 | $7,150 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 89 | 101 | $26,159 | $6,505 | 24.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 33 | 33 | $40,524 | $3,450 | 8.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 53 | 65 | $47,255 | $3,355 | 7.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 69 | 74 | $13,246 | $2,571 | 19.4% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 20 | 20 | $18,280 | $1,649 | 9.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 14 | 14 | $4,102 | $278.28 | 6.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 111 | 111 | $38,334 | $10,201 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 111 | 131 | $32,873 | $8,881 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 145 | 193 | $32,867 | $8,230 | 25.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2022 | 68 | 68 | $82,028 | $7,404 | 9.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 51 | 75 | $52,281 | $4,116 | 7.9% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 33 | 34 | $30,329 | $3,257 | 10.7% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2022 | 11 | 14 | $40,222 | $2,527 | 6.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 19 | 19 | $8,905 | $2,343 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 17 | 17 | $3,554 | $569.86 | 16.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 22 | 23 | $6,739 | $537.08 | 8.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2022 | 11 | 11 | $3,399 | $274.78 | 8.1% |
| 51595 | Removal of bladder and lymph nodes on both sides of pelvis with transplantation of urinary ducts (ureters) to small or large bowel with creation of urinary opening | Facility | 2021 | 11 | 11 | $338,304 | $18,655 | 5.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 146 | 186 | $39,302 | $12,309 | 31.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 97 | 97 | $31,425 | $9,199 | 29.3% |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | Facility | 2021 | 80 | 80 | $94,960 | $8,987 | 9.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 36 | 36 | $15,708 | $4,923 | 31.3% |
| 52235 | Destruction and/or removal of (2.0 to 5.0 centimeters) medium growths of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 21 | 24 | $68,952 | $4,861 | 7.0% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 54 | 84 | $55,524 | $4,581 | 8.3% |
About Dr. Thomas Keane, MD
Dr. Thomas Keane, MD is a Urology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972558708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Keane, MD has received a total of $70,386 in payments from pharmaceutical and medical device companies, with $125.63 received in 2024. These payments were reported across 89 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($39,532).
As a Medicare-enrolled provider, Keane has provided services to 2,183 Medicare beneficiaries, totaling 2,499 services with total Medicare billing of $202,060. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Charleston, SC
- Active Since 05/23/2006
- Last Updated 10/15/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1972558708
Products in Payments
- FIRMAGON (Drug) $19,437
- ORGOVYX (Drug) $12,411
- Xofigo (Drug) $6,224
- ELIGARD (Drug) $5,531
- Erleada (Drug) $5,371
- NOCDURNA (Drug) $5,292
- Rubraca (Drug) $3,281
- Nubeqa (Drug) $2,296
- Xtandi (Drug) $2,259
- ZYTIGA (Drug) $2,160
- iLED 7 Surgical Light (Device) $1,500
- Axumin (Drug) $1,201
- ERLEADA (Drug) $1,100
- LITHOVUE (Device) $636.84
- XTANDI (Drug) $621.51
- GENERAL PELVIC ORGAN PROLAPSE (Device) $203.00
- GENERAL - KIDNEY STONE DISEASE (Device) $170.24
- JELMYTO (Drug) $141.22
- Uronav (Device) $46.60
- ENZALUTAMIDE (Drug) $33.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Charleston
Eric Rovner, Md, MD
Urology — Payments: $367,935
Urology $367,935
Dr. Sandip Prasad, Md, Mphil, MD, MPHIL
Urology — Payments: $102,389
Urology $102,389
Dr. Ian Marshall, M. D, M. D
Urology — Payments: $71,598
Urology $71,598
Stephen Savage, Md, MD
Urology — Payments: $29,716
Urology $29,716
John Adams, Md, MD
Urology — Payments: $21,374
Urology $21,374
Dr. John Britton, M. D, M. D
Urology — Payments: $15,500
Urology $15,500